Antigen-specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy.
Saved in:
| Title: | Antigen-specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy. |
|---|---|
| Authors: | Kelderman S; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Heemskerk B; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Fanchi L; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Philips D; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Toebes M; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kvistborg P; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Buuren MM; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Rooij N; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Michels S; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Germeroth L; Stage Cell Therapeutics GmbH, Göttingen, Germany., Haanen JB; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schumacher NM; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. |
| Source: | European journal of immunology [Eur J Immunol] 2016 Jun; Vol. 46 (6), pp. 1351-60. Date of Electronic Publication: 2016 May 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
